2m 2m 2m 2m 2m 2m 2m
Solventum (SOLV)
NYSE
$88.23+$1.55 (+1.79%)
Price as of Oct 22, 2026 7:30 PM EDT- $14.8BMarket Cap
- 19.12%1-Year Change
- Medical Instruments & SuppliesIndustry
Solventum (SOLV)
$88.23+$1.55 (+1.79%)
SOLV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $86.67 | ||
Change | +$0.28 (+0.32%) | ||
Open | $85.74 | ||
High | $86.88 | ||
Low | $85.35 | ||
Previous Close | $86.39 | ||
Volume | 812,799 | ||
30-Day Average Volume | 913,770 | ||
1-Week Change | -0.68% | ||
1-Month Change | -2.44% | ||
1-Year Change | 19.12% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 170.2M | ||
Total Assets | $14.2B | ||
Market Cap | $14.8B | ||
Enterprise Value | $19.4B | ||
Period: QTR TTM FY | |||
Revenue | $1.7B | ||
Net Income | $92.0M | ||
Free Cash Flow | $144.0M | ||
EBIT | $171.0M | ||
EBITDA | $304.0M | ||
Net Working Capital | $78.0M | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 3 | ||
P/E | 164 | ||
PEG | 0 | ||
Price/Free Cash Flow | 102 | ||
Price/Operating Cash Flow | 65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue